D-dimer rise in outpatients with COVID 19 and comorbidities

Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Miljković Ana R.
Formato:	article
Lenguaje:	EN SR
Publicado:	Serbian Medical Society, Belgrade 2021
Materias:	d-dimer covid-19 comorbidity pulmonary thromboembolism general practice Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b64e7e57dc664c6cbde2f3ebf63d26c5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b64e7e57dc664c6cbde2f3ebf63d26c5
record_format	dspace
spelling	oai:doaj.org-article:b64e7e57dc664c6cbde2f3ebf63d26c52021-12-05T21:29:01ZD-dimer rise in outpatients with COVID 19 and comorbidities0354-71322217-399410.5937/opmed2102047Mhttps://doaj.org/article/b64e7e57dc664c6cbde2f3ebf63d26c52021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101047M.pdfhttps://doaj.org/toc/0354-7132https://doaj.org/toc/2217-3994Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases, diabetes, chronic pulmonary diseases, malignant diseases are at higher risk for the severe form of the disease. Case report: Female patient, 57, physician, presents with symptoms of Sars-Cov-2 virus infection. Her personal history is significant for pulmonary thromboembolism (PTE). This is a disease which should be paid special attention to. Conclusion: A new Coronavirus infection, which struck the world a year ago, presents a great challenge for general physicians (GPs) and the health system as a whole. The scientific and medical community and the general public must lean on verified facts in this fight against the COVID-19 pandemic. They should be ready to change their treatment protocols, as new information appears from properly designed, implemented, and presented basic and clinical studies. Each patient should be approached with special care, using up-todate facts and proofs from clinical practice, and guided by the newest treatment protocols thus reducing complications in COVID-19 patients with comorbidities.Miljković Ana R.Serbian Medical Society, Belgradearticled-dimercovid-19comorbiditypulmonary thromboembolismgeneral practiceMedicine (General)R5-920ENSROpšta Medicina, Vol 27, Iss 1-2, Pp 47-52 (2021)
institution	DOAJ
collection	DOAJ
language	EN SR
topic	d-dimer covid-19 comorbidity pulmonary thromboembolism general practice Medicine (General) R5-920
spellingShingle	d-dimer covid-19 comorbidity pulmonary thromboembolism general practice Medicine (General) R5-920 Miljković Ana R. D-dimer rise in outpatients with COVID 19 and comorbidities
description	Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases, diabetes, chronic pulmonary diseases, malignant diseases are at higher risk for the severe form of the disease. Case report: Female patient, 57, physician, presents with symptoms of Sars-Cov-2 virus infection. Her personal history is significant for pulmonary thromboembolism (PTE). This is a disease which should be paid special attention to. Conclusion: A new Coronavirus infection, which struck the world a year ago, presents a great challenge for general physicians (GPs) and the health system as a whole. The scientific and medical community and the general public must lean on verified facts in this fight against the COVID-19 pandemic. They should be ready to change their treatment protocols, as new information appears from properly designed, implemented, and presented basic and clinical studies. Each patient should be approached with special care, using up-todate facts and proofs from clinical practice, and guided by the newest treatment protocols thus reducing complications in COVID-19 patients with comorbidities.
format	article
author	Miljković Ana R.
author_facet	Miljković Ana R.
author_sort	Miljković Ana R.
title	D-dimer rise in outpatients with COVID 19 and comorbidities
title_short	D-dimer rise in outpatients with COVID 19 and comorbidities
title_full	D-dimer rise in outpatients with COVID 19 and comorbidities
title_fullStr	D-dimer rise in outpatients with COVID 19 and comorbidities
title_full_unstemmed	D-dimer rise in outpatients with COVID 19 and comorbidities
title_sort	d-dimer rise in outpatients with covid 19 and comorbidities
publisher	Serbian Medical Society, Belgrade
publishDate	2021
url	https://doaj.org/article/b64e7e57dc664c6cbde2f3ebf63d26c5
work_keys_str_mv	AT miljkovicanar ddimerriseinoutpatientswithcovid19andcomorbidities
_version_	1718370966810132480

D-dimer rise in outpatients with COVID 19 and comorbidities

Ejemplares similares